Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Gliosarcoma 1Glioblastoma 1Ependymoma 1Brain Stem Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 10Radiotherapy 4Bevacizumab 4etoposide phosphate 3Surgical Procedures, Operative 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Perfusion Magnetic Resonance Imaging 2O(6)-benzylguanine 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gadolinium DTPA 2Filgrastim 2Erlotinib Hydrochloride 2Dynamic Contrast Enhanced Magnetic Resonance Imaging 2Dexamethasone 2Congresses as Topic 2Carboplatin 2Calcium Dobesilate 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vocimagene amiretrorepvec 1varlilumab 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1talampanel 1sodium thiosulfate 1selinexor 1sargramostim 1regadenoson 1poly ICLC 1plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oligodendroglioma × imetelstat × Clear all
NCT01836549 2018-07-20

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Pediatric Brain Tumor Consortium

Phase 2 Terminated
43 enrolled 14 charts
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Oligodendroglioma, Gliosarcoma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡